Global Respiratory Drugs In-Depth Industrial and Market studies 2016-2020
Albany, New York, Feb 02, 2017
"Global
Respiratory Drugs Market 2016-2020"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Asthma,
COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and
IPF are some of the major respiratory diseases. Among these, asthma
and COPD are the most prevalent worldwide. Environmental pollution,
changing lifestyles, and hereditary factors are some of the common
causes of respiratory diseases. Intranasal corticosteroids,
antihistamines, immunosuppressants, bronchodilators, and leukotriene
antagonists are the respiratory medicines that are commonly used for
the treatment of mild-to-moderate respiratory diseases. However, the
choice of drug depends on the type and severity of the disease.
*
Technavios analysts forecast the global respiratory drugs market to
grow at a CAGR of 6.48% during the period 2016-2020.
– Covered in this report
The report covers the present scenario and the growth prospects of the global respiratory drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription and over-the-counter (OTC) drugs used to treat respiratory diseases.
– The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Respiratory Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
– Key vendors
AstraZeneca
Boehringer Ingelheim
F.Hoffman La-Roche
GlaxoSmithKline
Merck
Novartis
– Other prominent vendors
Abbott
Actavis
Afferent Pharmaceuticals
Alere
Almirall
Amgen
AptarGroup
Astellas
Aurobindo
Axis Shield
Baxter
Bayer
Biogen
Biotest
Bristol-Myers Squibb
Chiesi Farmaceutici
Cipla
Cytos
Dainippon Sumitomo
Dr. Reddy's Laboratories
FibroGen
Gilead Sciences
Glenmark
GNI Group Ltd
Horizon Pharma
ImmuneWorks
MediciNova
MedImmune
Mylan
Ono Pharmaceutical
Orchid Chemicals and Pharmaceuticals
Perrigo
Pfizer
Promedior
Prometheus
ProMetic Life Sciences
Ranbaxy
Rottapharm Madaus
Sanofi
Shionogi
Siemens Healthcare Diagnostics
Skyepharma
Sosei
Sunovion
Takeda Pharmaceutical
Teva
Theravance
United Therapeutics
Vectura
Vertex
Zai Lab
– Market driver
Rise in prevalence of respiratory diseases
For a full, detailed list, view our report
– Market challenge
Unknown etiology of asthma and idiopathic pulmonary fibrosis
For a full, detailed list, view our report
– Market trend
Use of biologics
For a full, detailed list, view our report
– Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
– Covered in this report
The report covers the present scenario and the growth prospects of the global respiratory drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription and over-the-counter (OTC) drugs used to treat respiratory diseases.
– The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Respiratory Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
– Key vendors
AstraZeneca
Boehringer Ingelheim
F.Hoffman La-Roche
GlaxoSmithKline
Merck
Novartis
– Other prominent vendors
Abbott
Actavis
Afferent Pharmaceuticals
Alere
Almirall
Amgen
AptarGroup
Astellas
Aurobindo
Axis Shield
Baxter
Bayer
Biogen
Biotest
Bristol-Myers Squibb
Chiesi Farmaceutici
Cipla
Cytos
Dainippon Sumitomo
Dr. Reddy's Laboratories
FibroGen
Gilead Sciences
Glenmark
GNI Group Ltd
Horizon Pharma
ImmuneWorks
MediciNova
MedImmune
Mylan
Ono Pharmaceutical
Orchid Chemicals and Pharmaceuticals
Perrigo
Pfizer
Promedior
Prometheus
ProMetic Life Sciences
Ranbaxy
Rottapharm Madaus
Sanofi
Shionogi
Siemens Healthcare Diagnostics
Skyepharma
Sosei
Sunovion
Takeda Pharmaceutical
Teva
Theravance
United Therapeutics
Vectura
Vertex
Zai Lab
– Market driver
Rise in prevalence of respiratory diseases
For a full, detailed list, view our report
– Market challenge
Unknown etiology of asthma and idiopathic pulmonary fibrosis
For a full, detailed list, view our report
– Market trend
Use of biologics
For a full, detailed list, view our report
– Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Comments
Post a Comment